Polyarteritis Nodosa: ['A necrotizing vasculitis that affects medium-sized arteries, it is usually idiopathic, and may be triggered by viral infections (Hepatitis B, also others). A multisystem disease, it most commonly affects skin (nodules, livedo reticularis) and peripheral nerves; higher morbidity is associated with gastrointestinal, central nervous system, cardiac, and/or other organ involvement. Anti-neutrophil cytoplasmic antibodies (ANCA) are typically negative. [ NCI ]']
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
472 |
4. Check minimum number of eventsNone |
472 |
5. Include endpoints |
514 |
6. Filter based on genotype QC (FinnGen only) |
514 |
Control definitions (FinnGen only)
- Control exclude
- M13_SYSTCONNECT
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M30-M36
- Name in latin
- Polyarteritis nodosa et condiciones cognatae
Similar endpoints
↥List of similar endpoints to
Polyarteritis nodosa and related conditions
based on the number of shared cases.
Similar with more cases:
- Systemic connective tissue disorders
- Autoimmune diseases related-to ILD
- Diseases of the musculoskeletal system and connective tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5194 | 2773 | 2381 |
| Only index persons | 3827 | 2036 | 1791 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.07 | 0.08 | 0.07 |
| Only index persons | 0.07 | 0.07 | 0.07 |
| Median age at first event (years) | |||
| Whole population | 43.91 | 57.85 | 27.24 |
| Only index persons | 38.04 | 54.00 | 19.89 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 514 | 304 | 210 |
| Unadjusted period prevalence (%) | 0.10 | 0.10 | 0.09 |
| Median age at first event (years) | 53.92 | 52.20 | 56.41 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 456
- Matched controls
- 4561
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M30.0
ICD-10 Finland
Polyarteritis nodosa
+∞
194.0
172
*
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
+∞
135.3
123
*
M30.8
ICD-10 Finland
Other conditions related to polyarteritis nodosa
+∞
86.2
80
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
10.8
72.8
154
205
H02AB06
ATC
prednisolone; systemic
5.8
65.8
329
1401
L04AX01
ATC
azathioprine; systemic
16.5
63.6
106
82
M30.3
ICD-10 Finland
Mucocutaneous lymph node syndrome [Kawasaki]
+∞
53.2
50
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.3
45.2
238
922
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
8.9
38.6
87
118
M31.3
ICD-10 Finland
Wegener granulomatosis
+∞
35.9
34
*
N08.5*M30.0
ICD-10 Finland
Glomerular disorders in polyarteritis nodosa
+∞
35.9
34
*
D72.1
ICD-10 Finland
Eosinophilia
68.9
33.6
38
6
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
6.4
32.7
92
172
L04AA06
ATC
mycophenolic acid; systemic
22.1
31.6
46
23
4461A
ICD-9 Finland
Polyarteritis nodosa and allied conditions, Acute febrile mucocutaneous lymph node syndrome [MCLS]
+∞
29.5
28
*
M05BA04
ATC
alendronic acid; oral
5.8
29.1
88
179
J45.9
ICD-10 Finland
Asthma, unspecified
3.9
28.8
138
452
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
3.8
28.8
148
514
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.0
27.7
246
1270
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
7.5
25.8
63
95
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
+∞
25.2
24
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.7
24.9
93
237
R50.9
ICD-10 Finland
Fever, unspecified
3.9
24.3
114
360
L01AA01
ATC
cyclophosphamide; systemic
59.5
24.3
28
5
N08.5
ICD-10 Finland
Glomerular disorders in systemic connective tissue disorders
+∞
24.2
23
*
M31.8
ICD-10 Finland
Other specified necrotizing vasculopathies
+∞
24.2
23
*
H02AB07
ATC
prednisone; oral
4.1
24.0
106
317
J45.1
ICD-10 Finland
Nonallergic asthma
5.6
23.6
73
151
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
38.6
23.3
29
8
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
10.0
23.2
47
52
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.0
22.4
160
690
M31.7
ICD-10 Finland
Microscopic polyangiitis
+∞
22.1
21
*
J01MA12
ATC
levofloxacin; systemic
3.5
22.0
121
430
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
+∞
21.0
20
*
TGC00
NOMESCO Finland
Bronchial lavation
12.5
20.6
37
32
UDH02
NOMESCO Finland
Rhinopharyngoscopy
5.5
20.3
63
130
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
7.0
19.8
50
79
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.5
19.8
61
125
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
7.1
19.3
48
74
C03CA01
ATC
furosemide; systemic
2.7
19.3
169
813
ZX120
NOMESCO Finland
Intravenous
4.2
19.2
79
219
P01BA02
ATC
hydroxychloroquine; oral
5.2
19.0
61
131
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.2
18.8
77
212
H02AB04
ATC
methylprednisolone; systemic
3.4
18.0
98
342
J32.4
ICD-10 Finland
Chronic pansinusitis
15.6
17.4
28
19
A02BC02
ATC
pantoprazole; systemic
2.4
17.3
305
2086
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
+∞
16.8
16
*
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
5.4
16.7
51
103
I77.6
ICD-10 Finland
Arteritis, unspecified
+∞
15.7
15
*
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
88.2
15.7
17
*
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
88.2
15.7
17
*
R03DC03
ATC
montelukast; oral
3.0
15.6
100
389
R03AC12
ATC
salmeterol; inhalant
6.2
15.5
42
73
J01FF01
ATC
clindamycin; systemic
2.5
15.3
151
759
J45.0
ICD-10 Finland
Predominantly allergic asthma
3.8
14.9
67
199
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.1
14.9
60
162
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
7.7
14.8
34
47
N02AX02
ATC
tramadol; systemic, rectal
2.3
14.7
205
1213
4460A
ICD-9 Finland
Polyarteritis nodosa and allied conditions, Polyarteritis nodosa[POLYARTERITIS NODOSA (CLASSICA)]
+∞
14.7
14
*
N08.5*M31.7
ICD-10 Finland
Glomerular disease states in microscopic polyangiitis
+∞
14.7
14
*
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
154.8
14.5
15
*
R03AK06
ATC
salmeterol and fluticasone; inhalant
3.1
14.5
88
326
N03AX16
ATC
pregabalin; oral
2.6
14.4
127
596
D69.0
ICD-10 Finland
Allergic purpura
19.9
14.4
21
11
TDM10
NOMESCO Finland
Puncture of maxillary antrum
6.2
14.1
38
66
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
9.8
13.7
27
29
M31.1
ICD-10 Finland
Thrombotic microangiopathy
+∞
13.6
13
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.8
13.6
95
389
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
4.0
13.4
55
151
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.4
13.4
142
732
R01AD08
ATC
fluticasone; nasal
2.3
13.4
147
769
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.6
13.3
63
196
PAW37
NOMESCO Finland
Biopsy of temporal artery
41.4
13.2
16
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
13.2
116
540
Z01.8
ICD-10 Finland
Other specified special examinations
2.6
13.2
113
518
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
8.5
13.0
28
35
R03AK08
ATC
formoterol and beclometasone; inhalant
6.6
13.0
33
53
R03AC02
ATC
salbutamol; inhalant
2.1
12.9
253
1707
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.6
12.7
103
457
N085, M318
ICD-10 Finland
NA
+∞
12.6
12
*
M35.3
ICD-10 Finland
Polymyalgia rheumatica
13.7
12.5
21
16
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
6.3
12.5
33
56
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.7
12.5
92
387
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
4.1
12.4
49
130
J01MA14
ATC
moxifloxacin; systemic
3.5
12.1
59
187
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
27.5
12.1
16
6
J45.8
ICD-10 Finland
Mixed asthma
6.4
12.0
31
51
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
4.9
12.0
39
85
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
3.6
11.9
54
162
A02BC01
ATC
omeprazole; systemic
2.2
11.9
143
773
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.4
11.9
115
562
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.4
11.8
59
191
R03BB04
ATC
tiotropium bromide; inhalant
3.3
11.6
60
200
F02.89*M30.0
ICD-10 Finland
Dementia in polyarteritis nodosa
+∞
11.5
11
*
M31.0
ICD-10 Finland
Hypersensitivity angiitis
+∞
11.5
11
*
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
10.9
11.4
21
20
XG474
NOMESCO Finland
Exhalation nntrogen oxide
6.4
11.2
29
48
XG410
NOMESCO Finland
Flow-volume spirometry
4.7
11.2
38
87
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.1
11.1
44
117
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.3
11.1
56
183
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
7.2
11.0
26
38
J01MA02
ATC
ciprofloxacin; systemic
2.0
11.0
184
1140
N30.1
ICD-10 Finland
Interstitial cystitis (chronic)
12.3
10.9
19
16
DHA10
NOMESCO Finland
Biopsy of cavity of nose
16.0
10.9
17
11
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
7.3
10.7
25
36
DPA30
NOMESCO Finland
Sphenotomy
61.5
10.7
12
*
L04AA01
ATC
[U] ciclosporin; systemic
10.4
10.6
20
20
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
+∞
10.5
10
*
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
+∞
10.5
10
*
J47
ICD-10 Finland
Bronchiectasis
11.7
10.1
18
16
R03BA05
ATC
fluticasone; inhalant
2.3
10.1
100
489
J33.0
ICD-10 Finland
Polyp of nasal cavity
6.0
10.1
27
47
H26.3
ICD-10 Finland
Drug-induced cataract
41.0
10.0
12
*
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.3
9.9
50
163
Z49.1
ICD-10 Finland
Extracorporeal dialysis
9.0
9.9
20
23
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.8
9.9
67
265
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
26.7
9.9
13
5
A12AA04
ATC
calcium carbonate; oral
9.9
9.9
19
20
A11CC03
ATC
alfacalcidol; systemic
5.8
9.8
27
49
R03BA02
ATC
budesonide; inhalant
2.3
9.7
97
475
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.6
9.7
43
127
R03DA04
ATC
theophylline; systemic, rectal
4.0
9.7
38
101
N02AA05
ATC
oxycodone; systemic
2.6
9.6
75
324
R03AC13
ATC
formoterol; inhalant
4.3
9.5
34
83
G58.7
ICD-10 Finland
Mononeuritis multiplex
102.1
9.4
10
*
44600
ICD-8 Finland
Polyarteritis nodosa and allied conditions, Polyarteritis nodosa
+∞
9.4
9
*
H02AB09
ATC
hydrocortisone; systemic
5.3
9.2
27
53
A12BA01
ATC
potassium chloride; oral
4.2
9.2
34
86
M05BA01
ATC
etidronic acid; systemic
37.5
9.1
11
*
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
3.3
9.0
45
147
A46
ICD-10 Finland
Erysipelas
2.5
8.9
72
317
XW000
NOMESCO Finland
Bone marrow biopsy
4.6
8.9
30
69
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.3
8.9
45
148
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.3
8.9
92
459
C08CA01
ATC
amlodipine; oral
1.9
8.7
152
937
L95.8
ICD-10 Finland
Other vasculitis limited to skin
16.7
8.6
13
8
D64.9
ICD-10 Finland
Anaemia, unspecified
2.8
8.6
57
224
J33.8
ICD-10 Finland
Other polyp of sinus
6.2
8.6
22
37
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
20.5
8.5
12
6
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
6.9
8.5
20
30
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
8.4
85
418
J01DB01
ATC
cefalexin; oral
2.0
8.4
361
3010
Z94.0
ICD-10 Finland
Kidney transplant status
8.8
8.4
17
20
L95.0
ICD-10 Finland
Livedoid vasculitis
+∞
8.4
8
*
297
Kela drug reimbursment
NA
+∞
8.4
8
*
R03DX09
ATC
mepolizumab; parenteral
+∞
8.4
8
*
3028
Kela drug reimbursment
Mepolizumab
+∞
8.4
8
*
N08.5*M31.0
ICD-10 Finland
Glomerular disorders in Goodpasture's syndrome
+∞
8.4
8
*
R03AK07
ATC
formoterol and budesonide; inhalant
2.2
8.3
90
457
R01AD01
ATC
beclometasone; nasal
2.3
8.2
77
365
R07.4
ICD-10 Finland
Chest pain, unspecified
2.0
8.2
127
749
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.5
8.2
37
112
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
4.5
8.2
28
66
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
8.2
128
755
S97
ICPC
Chronic ulcer skin
3.8
8.1
33
91
DHB20
NOMESCO Finland
Polypectomy of internal nose
9.2
8.1
16
18
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
22.5
8.0
11
5
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.2
8.0
85
428
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.8
8.0
53
206
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.2
7.9
86
438
R03BA01
ATC
beclometasone; inhalant
2.4
7.9
72
336
M13.9
ICD-10 Finland
Arthritis, unspecified
3.1
7.8
41
139
N06AA09
ATC
amitriptyline; systemic
2.7
7.8
52
204
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
45.8
7.7
9
*
N03AX12
ATC
gabapentin; oral
2.3
7.7
74
357
KCV04
NOMESCO Finland
Distension of bladder with fluid
12.1
7.6
13
11
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
12.1
7.6
13
11
A01AB09
ATC
miconazole; local oral
2.8
7.6
49
190
127
Kela drug reimbursment
Transplant complication
7.3
7.5
17
24
C07AB07
ATC
bisoprolol; oral
1.8
7.5
202
1422
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
6.1
7.5
19
32
GD1AD
NOMESCO Finland
Thorax CT examination
4.3
7.4
26
63
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.5
7.4
33
99
R03BA08
ATC
ciclesonide; inhalant
2.9
7.3
43
157
4476A
ICD-9 Finland
Other disorders of arteries and arterioles, Arteritis, unspecified
+∞
7.3
7
*
M31.6
ICD-10 Finland
Other giant cell arteritis
+∞
7.3
7
*
M35.1
ICD-10 Finland
Other overlap syndromes
+∞
7.3
7
*
UDM02
NOMESCO Finland
Sinoscopy
6.0
7.3
19
33
TK800
NOMESCO Finland
Hemodialysis
5.2
7.2
21
42
L04AD01
ATC
ciclosporin; systemic
5.8
7.1
19
34
J46
ICD-10 Finland
Status asthmaticus
4.5
7.1
24
56
A02BC05
ATC
esomeprazole; systemic
1.8
7.1
171
1159
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
4.2
7.0
25
62
J01FA06
ATC
roxithromycin; oral
1.7
7.0
179
1237
A07AA02
ATC
nystatin; oral
3.1
7.0
37
127
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
14.0
6.9
11
8
N30.0
ICD-10 Finland
Acute cystitis
2.2
6.9
75
380
TQW80
NOMESCO Finland
Local dermatologic skincare
5.2
6.9
20
40
N18.0
ICD-10 Finland
End-stage renal disease
8.5
6.9
14
17
WZC30
NOMESCO Finland
Teaching
2.3
6.9
64
303
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
5.5
6.8
19
36
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
40.7
6.8
8
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.8
6.8
43
165
B03XA02
ATC
darbepoetin alfa; parenteral
6.6
6.7
16
25
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.0
6.7
96
546
TPH07
NOMESCO Finland
Cathetrisation of artery
2.5
6.7
53
232
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.9
6.6
99
572
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.5
6.6
49
206
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.8
6.6
42
161
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
8.9
6.6
13
15
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.1
6.5
73
376
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
3.7
6.5
27
77
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
6.5
198
1429
A02BC03
ATC
lansoprazole; oral
1.8
6.5
129
820
Z2446
NOMESCO Finland
Social worker
2.6
6.5
45
182
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
4.5
6.4
21
48
B01AA03
ATC
warfarin; systemic
2.0
6.4
92
519
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
5.0
6.4
19
39
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
6.4
224
1679
R06AE07
ATC
cetirizine; oral
1.7
6.4
190
1361
ZX100
NOMESCO Finland
Oral
6.7
6.4
15
23
R03AK11
ATC
formoterol and fluticasone; inhalant
5.7
6.4
17
31
R03DC01
ATC
zafirlukast; oral
6.1
6.4
16
27
N085, M319
ICD-10 Finland
NA
+∞
6.3
6
*
J99.1*M31.3
ICD-10 Finland
Respiratory disorders in Wegener's granulomatosis
+∞
6.3
6
*
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
+∞
6.3
6
*
N08.5*M31.1
ICD-10 Finland
Glomerular disorders in thrombotic thrombocytopenic purpura
+∞
6.3
6
*
M81.4
ICD-10 Finland
Drug-induced osteoporosis
27.1
6.2
8
*
WX892
NOMESCO Finland
Monitored bed care
2.5
6.2
46
193
J01FA10
ATC
azithromycin; systemic
1.6
6.2
249
1933
AA1AD
NOMESCO Finland
CT of head and brain
1.8
6.1
105
636
1XC02
NOMESCO Finland
NA
12.7
6.1
10
8
JN4AD
NOMESCO Finland
Body CT examination
2.7
6.1
39
150
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
10.2
6.1
11
11
ZXD05
NOMESCO Finland
Urgent procedure
1.7
6.0
142
946
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
106
59
22.37
135.84
2.5
1.1
titre
46.7
—
—
6
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
102
95
13.15
97.98
4.6
1.2
iu/ml
10.3
—
—
19
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
85
59
17.06
96.90
4.0
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
176
467
5.21
64.50
1.8
1.3
titre
629.1
407.9
0.69
44
96
(3005719) IgG [Mass/volume] in Serum or Plasma
130
281
5.85
59.84
5.3
3.0
g/l
9.4
10.2
1.08
124
256
(3015171) Extractable nuclear Ab [Units/volume] in Serum
75
119
7.21
46.61
1.4
1.1
u/ml
0.2
3.9
—
5
7
(3021440) Promyelocytes/100 leukocytes in Blood
118
297
4.86
44.73
7.3
3.9
%
0.0
0.1
2.43
46
94
(3017181) Myelocytes/100 leukocytes in Blood
121
316
4.70
43.76
7.2
3.9
%
0.6
0.9
0.80
46
102
(42870588) Differential panel, method unspecified - Blood
280
1318
3.47
42.54
13.4
5.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
67
104
7.26
42.38
3.3
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
113
288
4.75
42.02
6.7
3.8
%
0.3
0.4
0.43
39
74
(3022096) Basophils/100 leukocytes in Blood
332
1794
3.40
39.06
16.8
5.7
%
0.7
0.7
0.16
323
1677
(3019069) Monocytes/100 leukocytes in Blood
337
1856
3.37
38.02
17.1
6.0
%
8.4
8.5
0.29
329
1748
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
40
37
11.64
37.75
1.5
1.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
335
1849
3.33
37.44
16.5
5.6
%
3.0
2.8
0.43
327
1729
(3002030) Lymphocytes/100 leukocytes in Blood
341
1917
3.31
36.63
16.6
5.7
%
24.5
28.4
9.78
334
1799
(3001604) Monocytes [#/volume] in Blood
346
1962
3.34
36.62
15.5
5.6
e9/l
0.6
0.6
3.60
332
1705
(3005322) IgE [Units/volume] in Serum or Plasma
96
239
4.71
36.48
2.2
1.2
u/ml
241.8
254.0
0.03
91
217
(3006315) Basophils [#/volume] in Blood
346
1968
3.32
36.31
15.6
5.6
e9/l
0.0
0.0
0.23
332
1713
(3013115) Eosinophils [#/volume] in Blood
353
2038
3.34
35.98
16.6
5.9
e9/l
0.2
0.2
1.22
340
1801
(3018010) Neutrophils/100 leukocytes in Blood
336
1886
3.26
35.92
15.7
5.5
%
60.7
56.9
7.60
328
1777
(3025159) Blasts/100 leukocytes in Blood
104
281
4.39
35.56
7.8
4.0
%
0.0
0.1
0.57
42
81
(3019198) Lymphocytes [#/volume] in Blood
349
2023
3.26
34.88
15.8
5.6
e9/l
1.8
2.0
1.40
337
1793
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
48
70
7.46
31.93
7.2
7.6
iu/ml
439.3
142.2
—
9
10
(3023368) Bacteria identified in Blood by Culture
221
1033
3.00
31.71
6.1
4.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
108
326
3.93
31.54
10.2
7.5
mmol/l
10.8
9.2
1.19
103
310
(3036481) Cortisol [Moles/volume] in Serum or Plasma
114
358
3.81
31.44
2.8
1.8
nmol/l
298.2
377.7
4.17
108
328
(3020630) Protein [Mass/volume] in Serum or Plasma
98
278
4.12
31.18
2.1
2.7
g/l
64.7
66.7
1.58
89
251
(3003458) Phosphate [Moles/volume] in Serum or Plasma
137
495
3.41
30.41
10.0
5.7
mmol/l
1.1
1.1
0.14
131
454
(3024980) IgG subclass 4 [Mass/volume] in Serum
43
60
7.73
29.69
1.7
1.8
g/l
1.0
0.8
0.21
29
50
(3028192) IgG subclass 2 [Mass/volume] in Serum
33
34
10.30
28.83
1.7
1.3
g/l
2.8
2.5
0.37
22
25
(3027135) IgG subclass 1 [Mass/volume] in Serum
33
34
10.30
28.83
1.7
1.3
g/l
6.1
5.8
0.25
21
25
(4062490)
33
34
10.30
28.83
1.7
1.3
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
33
34
10.30
28.83
1.7
1.3
g/l
0.4
0.3
0.27
22
24
(3013650) Neutrophils [#/volume] in Blood by Automated count
364
2298
3.00
28.69
18.1
8.7
e9/l
4.9
4.1
5.82
352
2018
(3004588) Protein electrophoresis panel - Serum or Plasma
83
221
4.29
28.65
2.2
2.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
318
1883
2.81
28.09
12.0
6.7
mmol/l
1.2
1.2
1.21
273
1596
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
118
410
3.44
27.66
4.1
4.5
u/l
241.1
260.0
0.40
112
393
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
296
1717
2.71
26.79
10.0
5.9
mmol/l
1.2
1.2
0.75
283
1550
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
44
73
6.50
25.90
5.4
3.1
%
61.1
57.6
0.77
44
73
(3030905) Polymorphonuclear cells [#/volume] in Blood
42
69
6.54
24.94
4.7
2.9
e9/l
4.9
4.5
0.44
42
69
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
275
1577
2.60
24.89
3.2
2.3
nmol/l
80.7
76.0
1.93
264
1405
(3000850) Epithelial cells [#/volume] in Urine
178
825
2.77
24.85
5.1
2.5
e6/l
4.5
5.7
0.39
167
725
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
41
69
6.37
23.77
1.3
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
271
1580
2.51
23.16
8.4
4.6
g/l
33.5
35.7
7.24
259
1477
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
248
1389
2.52
23.10
6.2
3.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
32
43
7.87
22.73
1.8
2.4
e9/l
1.2
1.4
0.26
15
22
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
44
83
5.70
22.71
1.6
1.1
u/ml
1.4
2.8
—
8
6
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
62
158
4.33
22.50
1.3
2.2
u/l
35.6
39.1
0.72
57
137
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
29
35
8.72
22.46
2.2
1.6
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
44
85
5.57
22.14
1.6
1.1
u/ml
4.0
3.8
—
8
7
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
51
113
4.90
21.99
1.8
1.5
iu/ml
0.2
0.2
0.06
11
18
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
52
121
4.67
21.13
2.8
2.8
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
58
148
4.29
20.98
2.4
1.9
ug/l
0.6
3.6
0.90
53
131
(3022948) Iron [Moles/volume] in Serum or Plasma
136
595
2.75
20.76
3.5
2.3
umol/l
11.5
13.2
2.26
129
554
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
83
275
3.41
20.63
5.0
4.0
mmol/l
1.6
1.7
0.09
67
195
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
208
1120
2.44
20.55
3.3
2.0
u/l
180.4
331.4
0.91
196
1051
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
123
518
2.81
20.15
4.0
2.3
%
20.6
22.7
1.08
108
456
(3023520) Reticulocytes [#/volume] in Blood
88
310
3.22
19.77
3.2
3.0
e9/l
73.4
72.6
0.06
70
239
(3009343) pH of Capillary blood
83
285
3.28
19.44
5.1
4.0
ph
7.4
7.4
1.70
16
27
(3002582) Erythrocytes [#/volume] in Urine
216
1208
2.36
19.33
6.1
3.1
e6/l
29.2
108.3
0.82
191
931
(3027945) Reticulocytes/100 erythrocytes in Blood
108
434
2.88
19.24
5.2
2.8
%
1.9
1.8
0.23
100
402
(40760888) Immunoglobulin light chains.free panel - Serum
37
70
5.62
19.00
1.8
4.9
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
126
553
2.69
18.95
3.7
2.3
g/l
2.3
2.4
0.60
118
514
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
57
158
3.93
18.40
1.7
2.2
g/l
1.6
1.4
0.60
47
142
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
31
51
6.40
18.32
1.6
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
39
81
5.13
18.08
3.6
3.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
239
1425
2.27
18.08
7.0
3.6
e6/l
53.3
77.8
0.68
194
1007
(3012095) Magnesium [Moles/volume] in Serum or Plasma
127
572
2.62
18.05
3.5
3.9
mmol/l
0.8
0.8
1.72
122
531
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
36
70
5.45
17.95
1.6
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
29
46
6.62
17.74
4.7
3.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
135
634
2.53
17.54
2.5
1.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
30
50
6.31
17.50
1.4
1.6
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
42
96
4.68
17.40
2.3
4.3
mg/l
29.3
29.7
0.03
30
74
(3034860) Kappa light chains.free [Mass/volume] in Serum
42
96
4.68
17.40
2.3
4.3
mg/l
48.0
124.0
0.56
31
74
(3026782) Osmolality of Urine
156
788
2.41
17.26
4.8
2.8
mosm/kgh2o
519.5
551.8
1.25
144
669
(3017143) Hepatitis C virus Ab [Presence] in Serum
110
473
2.69
17.08
1.9
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
199
1123
2.26
16.95
7.9
3.6
ph
7.4
7.4
0.71
53
204
(3007853) Bacteria identified in Skin by Aerobe culture
107
456
2.70
16.90
2.5
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
167
879
2.33
16.75
12.4
4.5
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
41
95
4.60
16.70
2.3
4.2
ratio
2.0
2.3
—
5
14
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
32
60
5.62
16.57
1.4
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
42
101
4.44
16.34
2.3
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
40
94
4.53
16.01
3.8
2.6
u/ml
0.4
0.3
0.29
26
48
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
37
82
4.78
15.90
1.8
1.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
21
26
8.38
15.87
1.8
1.2
u/ml
0.4
0.1
0.92
15
14
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
42
104
4.31
15.74
2.2
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
79
298
2.95
15.62
6.9
3.8
ng/l
110.9
76.1
2.04
72
269
(3013707) Erythrocyte sedimentation rate by Westergren method
389
2928
2.35
15.51
11.3
3.7
mm/h
15.6
11.7
4.50
376
2680
(3032080) INR in Blood by Coagulation assay
246
1557
2.11
15.26
12.3
8.5
inr
1.2
1.2
0.11
85
471
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
73
270
2.99
14.93
2.0
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
28
52
5.64
14.63
2.5
2.9
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
158
855
2.22
14.52
1.9
1.8
mg/l
1.2
1.2
0.08
128
666
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
33
72
4.83
14.44
2.4
1.6
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
18
21
8.85
14.21
1.5
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
130
654
2.32
14.19
1.9
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
153
824
2.22
14.18
2.0
1.4
g/l
2.4
2.3
0.31
117
497
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
16
16
10.29
14.09
1.2
1.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
269
1796
2.04
14.07
17.8
9.1
e9/l
0.0
0.0
0.01
249
1476
(3030467) Casts [#/volume] in Urine by Automated count
186
1086
2.12
14.00
6.0
3.1
e6/l
0.3
0.5
0.87
159
807
(3037756) Immunofixation for Serum or Plasma
33
74
4.70
13.97
1.2
1.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
369
2771
2.18
13.97
9.8
4.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
117
567
2.38
13.89
2.6
2.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
322
2305
2.06
13.76
6.4
4.7
mmol/l
6.9
6.7
0.72
312
2128
(3044927) Protein electrophoresis panel - Urine
22
34
6.72
13.75
1.2
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
146
782
2.21
13.65
2.1
1.9
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
14
12
11.97
13.58
2.0
1.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
34
81
4.42
13.37
1.5
1.4
u/ml
281.2
268.5
0.06
23
40
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
34
81
4.42
13.37
1.5
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
181
1061
2.09
13.37
5.8
3.0
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
21
32
6.80
13.29
1.7
2.1
e6/l
935.8
543.9
1.24
14
12
(3004809) Band form neutrophils/100 leukocytes in Blood
28
57
5.14
13.25
4.6
3.2
%
0.8
1.2
0.36
23
47
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
184
1090
2.07
13.18
4.1
3.1
ng/l
2197.4
1350.1
0.50
170
928
(3018677) aPTT in Platelet poor plasma by Coagulation assay
116
573
2.32
13.12
2.5
2.0
s
29.5
29.6
0.08
111
559
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
34
84
4.26
12.77
1.5
1.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
26
52
5.21
12.54
1.7
1.1
u/ml
6.4
1.3
—
10
17
(3037121) Protein [Mass/volume] in Urine
45
139
3.45
12.35
3.3
3.8
g/l
0.3
0.3
0.12
29
56
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
385
3012
2.11
12.06
14.8
7.0
u/l
75.8
79.9
1.17
376
2805
(3035350) Ketones [Presence] in Urine by Test strip
279
1960
1.93
11.87
6.3
3.6
estimate
0.0
0.0
0.00
86
374
(3021601) Nitrite [Presence] in Urine by Test strip
279
1969
1.91
11.62
8.2
4.9
estimate
0.0
0.0
0.00
91
372
(3004616) Nuclear Ab [Presence] in Serum
21
37
5.87
11.56
1.3
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
191
1192
1.96
11.50
5.5
3.1
mmol/l
7.3
7.6
0.38
164
1003
(3009261) Glucose [Presence] in Urine by Test strip
281
1992
1.91
11.50
6.2
3.6
estimate
0.0
0.0
0.50
88
363
(3029937) Albumin [Presence] in Urine by Test strip
175
1060
1.99
11.49
6.5
3.8
estimate
0.0
0.0
0.00
88
364
(3026493) Urate [Moles/volume] in Serum or Plasma
163
965
2.01
11.41
3.2
2.7
umol/l
1157.1
7074.3
2.78
144
838
(3048929) Epstein Barr virus Ab [Presence] in Serum
44
141
3.32
11.40
1.7
1.4
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
13
13
10.23
11.38
1.8
1.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
14
16
8.97
11.16
1.1
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
22
7.47
11.04
1.6
1.5
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
19
32
6.13
10.93
2.0
2.7
%
11.6
12.8
—
7
21
(3012516) Albumin [Mass/volume] in Urine
175
1076
1.95
10.90
5.7
3.3
mg/l
369.7
181.2
0.28
127
711
(3021879) Hepatitis B virus core Ab [Presence] in Serum
70
298
2.56
10.86
1.5
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
23
47
5.08
10.83
2.3
3.0
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
25
55
4.73
10.82
1.8
1.2
u/ml
3.3
3.6
0.09
11
22
(3021901) Oxygen saturation in Capillary blood
29
72
4.21
10.82
3.0
3.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
200
1291
1.90
10.72
3.5
3.2
mmol/l
2.3
2.4
3.55
184
1130
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
17
26
6.73
10.69
1.1
1.1
mg/l
64.5
29.2
0.73
12
20
(3038026) Centromere Ab [Units/volume] in Serum
16
23
7.15
10.63
1.4
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
30
78
4.02
10.54
2.5
2.3
%
16.7
16.0
0.43
23
36
(3020682) Albumin/Creatinine [Ratio] in Urine
181
1137
1.91
10.50
7.0
4.0
mg/mmol
18.8
11.2
0.86
131
726
(3017817) Protein [Mass] in Urine collected for unspecified duration
18
30
6.18
10.46
1.7
2.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
221
1482
1.86
10.45
6.2
3.6
ng/l
36.6
39.2
0.16
163
1012
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
38
118
3.40
10.34
2.9
2.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
38
118
3.40
10.34
2.9
2.2
g/l
7.3
7.4
0.08
28
91
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
38
118
3.40
10.34
2.9
2.2
g/l
3.8
3.8
0.05
26
86
(3027315) Oxygen [Partial pressure] in Blood
31
84
3.86
10.30
4.4
3.5
kpa
8.6
8.6
0.04
31
84
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
29
75
4.04
10.26
1.6
1.4
u/ml
96.0
107.2
—
5
15
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
14
18
7.97
10.19
1.6
1.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
18
31
5.98
10.13
1.8
2.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
280
2037
1.82
10.03
7.7
6.0
umol/l
11.9
11.2
0.23
275
1924
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
118
648
2.07
10.01
1.4
1.2
iu/ml
37.0
35.2
0.06
47
206
(3000494) Fungus identified in Specimen by Culture
93
468
2.21
9.87
2.2
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
81
385
2.31
9.85
7.0
3.8
mmol/l
1.6
1.8
0.21
72
305
(3001122) Ferritin [Mass/volume] in Serum or Plasma
248
1748
1.81
9.79
4.4
2.6
ug/l
203.8
112.2
1.70
243
1608
(3027801) Oxygen [Partial pressure] in Arterial blood
86
421
2.25
9.75
6.6
8.3
kpa
10.9
12.3
2.24
79
405
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
90
449
2.22
9.75
2.3
1.8
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
14
19
7.55
9.74
1.6
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
72
328
2.39
9.64
8.4
7.8
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
34
103
3.46
9.62
2.0
2.6
g/l
0.0
0.9
2.33
29
91
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
25
61
4.26
9.54
1.8
1.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
30
84
3.73
9.52
4.2
3.5
mmol/l
2.5
2.6
0.10
22
49
(3013290) Carbon dioxide [Partial pressure] in Blood
30
84
3.73
9.52
4.2
3.5
kpa
4.9
5.0
0.28
30
84
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
109
3.37
9.49
3.0
2.3
g/l
3.1
3.1
0.07
26
89
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
15
23
6.69
9.40
1.4
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
20
42
4.91
9.13
2.4
1.9
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
15
24
6.41
9.04
1.0
1.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
121
694
1.97
9.01
1.8
1.7
nmol/l
1194.4
1202.0
0.03
101
523
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
193
1292
1.79
8.82
3.9
3.2
u/l
46.3
33.4
0.47
179
1231
(3022313) Gas panel - Capillary blood
54
225
2.56
8.73
5.8
3.9
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
35
115
3.19
8.72
2.3
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
86
441
2.14
8.66
2.3
1.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
155
978
1.84
8.58
3.2
2.0
mg/l
3.1
3.1
0.02
145
840
(3003396) Base excess in Arterial blood by calculation
83
422
2.15
8.53
6.8
8.4
mmol/l
1.0
1.2
0.17
70
330
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
12
16
7.66
8.44
3.1
1.9
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
337
2667
1.77
8.38
7.1
4.3
e6/l
7978.5
1583.8
0.44
15
45
(3044290) Cell count panel - Cerebral spinal fluid
27
77
3.65
8.36
1.6
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
110
626
1.96
8.32
1.4
1.2
u/ml
14.5
13.6
0.04
43
248
(3014111) Lactate [Moles/volume] in Serum or Plasma
68
322
2.28
8.31
5.7
6.9
mmol/l
1.3
1.4
0.16
68
310
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
30
93
3.36
8.20
1.3
1.6
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
58
259
2.40
8.09
5.7
6.5
mmol/l
24.6
24.8
0.16
58
259
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
20
47
4.39
8.00
2.4
1.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
20
47
4.39
8.00
2.1
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
24
65
3.82
7.99
1.4
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
24
65
3.82
7.99
1.6
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
43
173
2.62
7.46
1.3
1.2
—
—
—
0
0
(3036489) Thrombin time
36
132
2.86
7.45
2.4
2.6
s
22.7
21.9
0.16
31
118
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
13
22
6.04
7.41
1.0
1.0
u/l
1.1
1.1
—
7
15
(3041096) Erythrocytes [Presence] in Urine by Automated
168
1128
1.73
7.34
6.0
3.2
—
—
—
0
0
(4268621)
17
38
4.59
7.23
3.1
2.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
16
34
4.82
7.21
2.7
2.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
11
16
7.00
7.17
3.3
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
11
16
7.00
7.17
3.3
1.9
—
—
—
0
0
(4015189)
10
13
7.83
7.14
2.6
2.9
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
178
1222
1.70
7.14
2.9
2.4
u/l
54.8
57.0
0.27
166
1136
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
18
43
4.30
7.06
1.3
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
17
39
4.47
7.01
2.6
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
17
39
4.47
7.01
2.6
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
17
39
4.47
7.01
2.6
1.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
15
31
4.95
6.97
1.8
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
19
48
4.07
6.95
2.5
2.5
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
10
6
16.96
6.77
1.4
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
52
240
2.30
6.74
6.8
6.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
50
228
2.32
6.66
4.9
2.5
e6/l
0.3
0.2
0.37
50
220
(3022145) Colonoscopy Study observation
78
425
1.98
6.61
1.3
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
12
21
5.83
6.61
1.0
1.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
11
9
12.46
6.61
2.2
3.0
—
—
—
0
0
(4035726)
63
318
2.12
6.57
1.3
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
73
394
1.99
6.35
4.4
3.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
13
26
5.10
6.25
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
13
26
5.10
6.25
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
13
26
5.10
6.25
1.2
1.2
—
—
—
0
0
(3019225) pH of Specimen
67
354
2.03
6.18
8.0
4.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
10
8
12.72
6.10
1.2
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
10
8
12.72
6.10
1.2
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
10
8
12.72
6.10
1.2
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
10
8
12.72
6.10
1.2
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
10
8
12.72
6.10
1.0
1.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
209
1542
1.60
6.09
6.4
3.7
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
13
27
4.91
6.00
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
13
27
4.91
6.00
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
13
27
4.91
6.00
1.2
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
16
6.35
5.97
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
16
6.35
5.97
1.0
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
65
344
2.02
5.97
7.0
3.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
174
1234
1.62
5.95
4.1
3.1
—
—
—
0
0
(4027681)
11
20
5.60
5.83
1.5
1.2
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
11
20
5.60
5.83
1.1
1.1
ratio
1.1
1.0
—
5
7
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
10
9
11.30
5.81
1.6
3.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
21
65
3.33
5.79
5.6
3.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
19
55
3.55
5.78
1.6
1.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
79
455
1.87
5.67
8.0
6.7
mmol/l
103.7
104.1
0.37
74
444
(3045142) Bone marrow Pathology biopsy report
15
37
4.15
5.66
1.1
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
11
21
5.33
5.54
1.1
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
36
154
2.44
5.54
2.9
1.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
115
745
1.70
5.54
4.2
3.7
ng/l
563.0
295.1
0.43
87
582
(3017354) Segmented neutrophils/100 leukocytes in Blood
15
38
4.04
5.47
3.7
2.8
%
51.9
64.2
—
9
26
(40768804) Tissue Pathology biopsy report
205
1537
1.56
5.42
2.3
2.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
48
235
2.15
5.41
2.8
2.4
—
16.7
—
0
10
(3003327) Ova and parasites identified in Stool by Light microscopy
33
137
2.51
5.41
2.0
1.6
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
42
195
2.26
5.39
4.2
9.4
mmol/l
23.5
24.5
1.26
37
185
(3033658) Prothrombin time (PT) actual/Normal
138
945
1.63
5.35
5.5
3.8
%
93.2
91.3
0.40
132
923
(40758558) Short blood count panel - Blood
146
1015
1.61
5.32
11.6
6.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
11
22
5.09
5.28
3.3
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
11
22
5.09
5.28
3.3
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
11
22
5.09
5.28
3.3
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
11
22
5.09
5.28
3.3
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
47
231
2.14
5.25
1.7
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
16
44
3.72
5.24
1.0
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
14
35
4.08
5.20
1.1
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
15
40
3.83
5.12
1.0
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
13
31
4.28
5.12
1.5
1.4
e6/l
132387.6
69581.2
—
7
17
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
238
1863
1.52
5.07
5.4
4.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
19
5.35
5.06
1.6
2.3
u/ml
1760.7
808.3
—
10
19
(3024891) Influenza virus A+B Ag [Presence] in Specimen
29
119
2.52
4.88
1.4
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
76
455
1.79
4.80
2.4
2.8
umol/l
11.6
8.4
0.29
67
396
(3013727) Leukocytes other/100 leukocytes in Blood
9
10
9.14
4.80
4.9
5.1
%
47.1
45.5
—
9
10
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
15
42
3.65
4.80
1.0
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
28
114
2.54
4.79
1.5
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
10
20
5.08
4.79
1.2
1.1
iu/ml
107.4
196.1
—
10
20
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
9
11
8.30
4.57
1.3
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
9
11
8.30
4.57
1.0
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
13
34
3.90
4.56
1.0
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
20
70
2.93
4.54
3.8
3.2
nmol/l
0.7
0.9
0.94
13
55
(3042733) HLA Ab [Presence] in Serum
8
8
10.13
4.53
5.9
2.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
22
82
2.76
4.47
1.8
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
22
82
2.76
4.47
1.8
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
166
1235
1.51
4.36
3.3
2.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
15
45
3.40
4.35
1.0
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
53
293
1.90
4.31
3.6
3.3
ng/l
237.3
190.2
0.30
48
262
(3024932) HLA-DR beta [Type]
8
9
9.01
4.29
1.1
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
8
9
9.01
4.29
1.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
12
31
3.94
4.28
1.2
2.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
198
1533
1.47
4.25
2.3
1.9
pmol/l
91.5
95.1
0.63
116
781
(3013512) EKG study
150
1099
1.52
4.22
5.4
3.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
31
142
2.26
4.14
1.9
1.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
80
508
1.68
4.10
3.1
2.1
ug/g
126.5
122.8
0.05
67
393
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
27
117
2.38
4.08
1.5
1.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
8
10
8.10
4.07
1.4
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
22
87
2.60
4.02
7.2
2.9
—
—
—
0
0
(44790049)
16
53
3.08
4.00
1.9
1.5
—
—
—
0
0
(44790048)
16
53
3.08
4.00
1.9
1.5
—
—
—
0
0
(44806118)
16
53
3.08
4.00
1.9
1.5
—
—
—
0
0
(44790047)
16
53
3.08
4.00
1.9
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
11
28
3.99
3.99
2.0
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
53
302
1.84
3.94
5.6
3.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
94
629
1.61
3.92
4.7
2.8
e6/l
2.7
2.7
0.01
55
347
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
11
7.37
3.87
1.1
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
23
95
2.49
3.86
2.4
2.4
ug/min
46.9
68.3
0.44
18
58
(3021788) Differential panel - Synovial fluid
17
60
2.90
3.83
1.9
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
12
34
3.59
3.78
1.2
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
440
4030
1.64
3.78
33.9
13.1
mg/l
22.5
23.1
0.16
404
3165
(40768806) Pleura Pathology biopsy report
13
39
3.39
3.78
1.4
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
13
39
3.39
3.78
1.2
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
5
12.12
3.77
1.7
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
15
50
3.06
3.71
21.5
7.2
mmol/l
6.8
6.4
0.23
15
38
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
8
12
6.75
3.68
1.1
1.0
%
91.4
98.0
—
8
12
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
12
6.75
3.68
1.1
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
11
30
3.72
3.65
1.7
1.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
12
35
3.49
3.64
1.1
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
12
35
3.49
3.64
1.1
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
34
171
2.06
3.63
2.0
1.9
—
—
—
0
0
(4010399)
49
281
1.82
3.58
1.9
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
10
26
3.90
3.53
1.4
1.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
10
26
3.90
3.53
1.2
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
127
933
1.48
3.45
3.1
2.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
18
5.07
3.38
1.0
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
14
5.79
3.35
3.0
6.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
75
495
1.60
3.31
1.3
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
6
7
8.65
3.27
1.3
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
6
7
8.65
3.27
1.3
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
38
208
1.89
3.22
2.1
1.6
—
—
—
0
0
(4306422)
14
49
2.91
3.21
1.1
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
60
379
1.66
3.15
2.1
2.4
u/l
31.4
158.4
0.50
52
321
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
21
92
2.34
3.14
2.0
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
14
50
2.85
3.11
1.4
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
15
56
2.73
3.08
1.3
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
15
56
2.73
3.08
1.2
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
6
8
7.57
3.06
1.2
1.4
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
8
7.57
3.06
1.3
1.6
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
10
29
3.50
3.06
1.7
2.2
ml
931.7
503.1
—
10
17
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
93
657
1.51
3.04
4.7
2.7
e6/l
0.6
1.0
0.77
55
371
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
12
5.90
3.03
1.0
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
48
289
1.73
3.01
4.8
2.5
ml/min/173m2
56.9
64.3
0.64
25
119
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
5
10.08
2.98
1.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
22
101
2.23
2.97
1.1
1.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
8
17
4.76
2.93
1.3
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
102
2.21
2.91
1.0
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
7
13
5.44
2.87
1.0
2.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
11
36
3.10
2.82
1.1
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
120
904
1.43
2.82
5.6
3.4
—
—
—
0
0
(3016750) Collection duration of Urine
9
23
3.96
2.78
1.7
2.1
min
535.7
484.6
—
9
14
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
35
197
1.83
2.75
8.9
11.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
6
8.40
2.75
2.4
1.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
16
347
0.44
2.73
1.6
1.6
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
24
3.80
2.68
1.7
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
24
3.80
2.68
1.7
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
68
463
1.54
2.64
1.4
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
11
38
2.94
2.59
1.1
1.1
u/ml
0.7
3.0
—
5
14
(3014133) Dog dander IgE Ab [Units/volume] in Serum
12
44
2.77
2.56
1.1
1.0
u/ml
1.0
1.1
—
6
16
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
7
7.20
2.55
1.0
5.9
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
11
5.50
2.55
1.0
1.0
miu/ml
1654.5
1282.1
—
6
11
(40765096) Chromosome analysis panel by Banding
6
11
5.50
2.55
1.0
1.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
11
5.50
2.55
1.2
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
49
313
1.63
2.49
4.2
2.2
ug/l
5.7
6.9
0.29
36
280
(3035880) pH of Pleural fluid
8
21
3.85
2.47
1.3
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
12
46
2.65
2.37
2.4
2.3
pg
31.3
32.6
0.35
12
46
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
22
3.68
2.37
5.0
3.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
22
3.68
2.37
1.3
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
8
22
3.68
2.37
2.0
5.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
10
35
2.89
2.31
1.2
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
244
0.40
2.31
1.3
1.4
—
—
—
0
0
(3000492) Spirometry study
54
362
1.55
2.26
1.9
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
54
2.44
2.21
1.1
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
64
448
1.49
2.20
1.6
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
22
115
1.95
2.19
3.1
3.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
24
3.37
2.19
1.0
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
15
68
2.24
2.13
1.9
1.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
12
49
2.48
2.12
1.5
1.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
90
682
1.39
2.03
2.7
2.8
mmol/l
2.5
2.5
0.01
80
600
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
18
90
2.04
2.03
2.4
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
112
880
1.35
2.02
6.7
3.7
kg/l
1.0
1.0
0.36
17
135
(3044242) Glucose [Moles/volume] in Arterial blood
8
26
3.11
2.02
1.4
4.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
38
2.66
2.02
1.6
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
65
466
1.45
2.00
22.0
21.1
inr
1.3
1.2
—
10
53
(3047007) Chlamydophila sp Ab [Presence] in Serum
13
57
2.31
1.99
1.1
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
21
3.36
1.97
1.7
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
21
3.36
1.97
1.7
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
7
21
3.36
1.97
1.3
1.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
7
21
3.36
1.97
2.3
1.5
ug/l
45.6
66.1
—
7
21
(3035947) Staphylolysin Ab [Units/volume] in Serum
7
21
3.36
1.97
1.4
1.1
iu/ml
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
33
2.76
1.94
1.1
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
22
3.21
1.88
1.0
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
22
3.21
1.88
1.0
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
15
72
2.12
1.88
1.4
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
28
2.89
1.87
1.0
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
113
901
1.33
1.85
1.9
1.5
nmol/l
19.1
20.9
0.86
102
782
(3003888) Timothy IgE Ab [Units/volume] in Serum
14
66
2.15
1.83
1.3
1.1
u/ml
9.4
4.1
—
6
42
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
48
2.32
1.71
1.1
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
19
3.18
1.66
1.0
1.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
290
2622
1.24
1.66
3.8
3.1
u/l
60.5
46.5
1.59
271
2459
(3025468) Yersinia sp identified in Specimen by Organism specific culture
11
49
2.27
1.64
2.7
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
11
49
2.27
1.64
2.7
1.5
—
—
—
0
0
(3020891) Body temperature
24
143
1.71
1.64
5.5
4.7
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
14
3.60
1.62
2.0
2.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
50
2.23
1.58
2.7
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
11
50
2.23
1.58
2.7
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
50
2.23
1.58
2.7
1.5
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
13
64
2.06
1.55
1.3
1.0
u/ml
0.3
1.1
—
5
11
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
10
44
2.30
1.54
6.1
3.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
38
259
1.50
1.53
4.9
3.1
e9/l
5.6
3.9
2.06
28
210
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
5
15
3.36
1.52
1.2
3.9
ug/l
2.4
2.3
—
5
15
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
15
3.36
1.52
1.2
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
52
378
1.42
1.52
3.1
3.8
ug/l
11.1
41.4
0.75
36
310
(3049717) Cytology report of Urine Cyto stain
22
131
1.71
1.52
2.5
2.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
117
1403
0.78
1.51
3.2
2.8
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
21
2.88
1.51
1.3
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
331
3060
1.23
1.45
4.3
3.9
pmol/l
15.0
14.7
1.34
305
2757
(3016650) Hepatitis A virus Ab [Presence] in Serum
12
59
2.06
1.44
1.1
1.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
13
66
1.99
1.44
1.0
1.1
—
15.8
—
0
5
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
16
3.14
1.44
1.2
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
16
3.14
1.44
1.8
2.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
16
3.14
1.44
1.0
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
22
2.75
1.44
1.2
1.4
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
10
48
2.10
1.28
1.2
1.1
g/l
1.7
1.4
—
10
42
(3044889) 12 lead EKG panel
296
2725
1.20
1.28
4.5
3.7
—
—
—
0
0
(3011648) Oxygen content in Venous blood
8
35
2.31
1.27
4.2
2.8
%
12.0
11.7
—
8
35
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
36
2.24
1.24
1.3
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
95
783
1.26
1.22
1.8
1.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
37
2.18
1.22
1.1
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
31
215
1.47
1.19
1.3
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
12
64
1.90
1.19
1.3
1.1
u/ml
0.5
2.1
—
7
39
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
14
79
1.79
1.18
1.4
1.1
u/ml
0.2
0.7
—
9
36
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
10
50
2.02
1.17
2.9
1.5
—
—
—
0
0
(4281824)
0
33
0.00
1.16
0.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
11
58
1.92
1.13
1.4
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
93
774
1.25
1.10
1.7
1.7
pmol/l
441.4
7645705.4
0.50
81
654
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
66
1.84
1.10
1.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
22
2.28
1.03
4.8
1.7
—
—
—
0
0
(3004451) EKG impression Narrative
5
22
2.28
1.03
1.4
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
5
22
2.28
1.03
1.8
2.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
11
60
1.85
1.03
1.2
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
48
1.89
1.01
1.2
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
5
23
2.19
0.98
1.4
1.3
mmol/l
5.2
6.7
—
5
23
(36660697) Celiac disease serology panel - Serum
42
322
1.33
0.95
1.2
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
29
393
0.72
0.93
1.2
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
386
3696
1.18
0.86
26.8
12.2
ml/min/173m2
79.1
82.5
1.73
340
3009
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
34
441
0.75
0.83
1.3
1.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
109
951
1.19
0.82
1.3
1.3
u/ml
1.6
1.5
0.07
21
253
(3020191) Ethanol [Moles/volume] in Serum or Plasma
6
32
1.88
0.82
1.2
1.4
promille
1.2
1.3
—
6
23
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
32
1.88
0.82
1.8
1.9
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
9
151
0.59
0.79
1.3
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
48
1.68
0.79
1.4
1.3
nmol/l
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
18
124
1.47
0.76
1.3
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
11
67
1.66
0.75
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
11
67
1.66
0.75
1.1
1.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
9
54
1.68
0.75
1.7
1.3
nmol/l
0.5
0.5
—
9
48
(4034850)
8
135
0.59
0.74
21.9
9.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
18
125
1.46
0.73
1.3
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
18
125
1.46
0.73
1.3
1.1
—
—
—
0
0
(44813793)
5
25
2.01
0.73
1.0
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
7
40
1.76
0.71
1.1
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
114
1012
1.16
0.71
1.6
1.7
mmol/l
1.6
1.4
1.16
102
857
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
7
117
0.59
0.68
1.4
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
17
119
1.44
0.67
1.8
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
381
3674
1.14
0.65
5.0
4.6
mu/l
2.0
1.9
0.44
356
3333
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
5
29
1.73
0.64
1.2
1.4
—
26.8
—
0
5
(40768793) Breast Pathology biopsy report
6
103
0.58
0.62
1.2
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
17
232
0.72
0.61
1.5
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
51
1.58
0.60
1.6
1.3
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
373
3600
1.13
0.60
6.9
5.6
mmol/mol
40.3
39.8
0.41
352
3356
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
280
2661
1.11
0.58
3.8
3.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(4094501)
14
98
1.44
0.57
1.1
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
8
55
1.46
0.56
2.3
1.9
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
37
1.63
0.55
2.7
1.9
%
13.6
13.4
—
6
37
(3003338) MCHC [Mass/volume]
333
3454
0.90
0.54
37.5
17.0
g/l
330.5
332.7
3.80
333
3427
(3027944) Amphetamines [Presence] in Urine
25
196
1.29
0.53
1.1
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
30
242
1.25
0.52
1.2
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
23
182
1.28
0.47
1.1
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
369
3789
0.91
0.43
5.1
4.3
mmol/l
5.9
5.9
0.46
343
3445
(4024509)
5
31
1.62
0.43
1.8
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
24
194
1.25
0.42
3.3
2.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
24
194
1.25
0.42
1.1
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
24
194
1.25
0.42
1.1
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
125
1157
1.11
0.42
1.7
1.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
16
0.00
0.41
0.0
4.1
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
16
0.00
0.41
0.0
1.1
—
331.9
—
0
10
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
54
475
1.15
0.41
4.2
4.3
%
33.8
31.6
0.77
42
317
(40765089) Chromosome analysis panel - Blood by G-banded
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
24
291
0.82
0.39
1.7
2.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
35
1.43
0.39
1.2
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
429
4209
1.12
0.39
26.6
12.6
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.2
—
3.6
—
0
13
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
5
76
0.65
0.36
3.6
1.8
pmol/l
212.8
239.1
—
5
71
(3005570) Glucose [Moles/volume] in Urine
6
43
1.40
0.35
2.2
2.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
56
624
0.88
0.35
2.5
3.0
ug/l
0.7
0.7
0.49
37
405
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
19
231
0.82
0.33
1.7
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
23
193
1.20
0.31
1.1
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
17
207
0.82
0.30
6.5
4.0
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
13
163
0.79
0.30
1.0
1.7
mg/l
7.1
3.8
—
7
110
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
79
854
0.91
0.29
4.2
4.3
%
21.5
21.4
0.02
40
403
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
9
118
0.76
0.27
1.2
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
9
118
0.76
0.27
1.2
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
9
118
0.76
0.27
1.2
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
9
118
0.76
0.27
1.2
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
26
225
1.16
0.26
1.2
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
75
1.20
0.25
2.4
1.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
17
144
1.19
0.22
1.4
1.6
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
41
1.22
0.22
1.0
1.9
ug/l
13.0
17.0
—
5
41
(3002619) Bacteria identified in Specimen by Culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
10
0.00
0.21
0.0
2.1
—
7422.7
—
0
10
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
104
0.77
0.21
1.4
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
104
0.77
0.21
2.0
1.7
—
—
—
0
0
(44806420)
0
13
0.00
0.21
0.0
2.8
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
18
155
1.17
0.20
1.2
2.3
u/l
13224.3
4704.8
—
9
66
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
53
1.13
0.18
1.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
13
109
1.20
0.18
1.7
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
11
132
0.83
0.18
1.4
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
49
455
1.09
0.18
10.3
6.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
111
1064
1.06
0.17
4.4
4.8
ug/l
2.3
2.4
0.13
99
958
(3001019) Free T4 and TSH panel - Serum or Plasma
22
196
1.13
0.16
1.8
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
10
118
0.84
0.14
5.5
5.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
17
152
1.12
0.12
2.2
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
49
515
0.95
0.11
2.6
2.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
17
154
1.11
0.10
1.1
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
17
154
1.11
0.10
1.1
1.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
28
261
1.08
0.10
2.6
2.6
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
44
1.14
0.10
1.0
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
382
3851
0.97
0.09
4.7
4.3
mmol/l
4.5
4.6
1.17
363
3576
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
373
3701
1.03
0.08
4.3
3.8
mmol/l
1.4
1.3
1.62
351
3397
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
380
3828
0.97
0.08
4.7
4.2
mmol/l
1.5
1.5
0.17
359
3531
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
61
0.82
0.08
1.8
1.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
65
0.77
0.08
4.2
2.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
83
0.84
0.07
1.0
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
9
85
1.06
0.07
1.2
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
90
0.89
0.07
3.3
2.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
15
138
1.09
0.06
2.7
1.5
mu/l
336.2
299.7
0.27
15
125
(3043238) Trisomy 21 risk [Likelihood] in Fetus
9
100
0.90
0.06
1.1
1.6
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
13
119
1.09
0.06
1.2
1.4
ug/g
340.6
291.9
—
5
72
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
46
474
0.97
0.05
2.2
2.1
—
—
—
0
0
(1002224) Polysomnography panel
15
159
0.94
0.03
1.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
23
222
1.04
0.02
1.0
1.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
49
482
1.02
0.01
1.4
1.7
%
1.5
1.5
0.01
42
426
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
45
444
1.01
0.00
1.6
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
12
117
1.03
0.00
1.2
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
13
127
1.02
0.00
1.7
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
64
645
0.99
0.00
1.6
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
28
281
1.00
0.00
1.2
1.2
iu/ml
34.3
138.3
—
10
112
(3009542) Hematocrit [Volume Fraction] of Blood
371
3706
1.00
0.00
29.3
14.3
%
39.2
39.9
0.85
255
2750
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
393
3934
1.00
0.00
5.0
4.8
mmol/l
2.6
2.7
2.77
372
3620
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
4.6
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
5
0.00
0.00
0.0
5.0
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
6
63
0.95
0.00
1.5
1.4
mmol/l
51.5
66.9
—
6
55
(4133840)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
9
97
0.93
0.00
1.1
1.5
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
2.0
—
0
6
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.9
—
55.5
—
0
7
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.0
—
1.1
—
0
6
(3005033) Fetal Nuchal fold Thickness US
9
97
0.93
0.00
1.1
1.4
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
8
87
0.92
0.00
1.5
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_POLYARTERETAL and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_POLYARTERETAL | 2.265 [1.92, 2.68] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.11 |
During the follow-up period (1.1.1998 — 31.12.2019), 770 out of 2094 females with M13_POLYARTERETAL died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_POLYARTERETAL | 2.27 [1.8, 2.86] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.006 |
During the follow-up period (1.1.1998 — 31.12.2019), 372 out of 1721 males with M13_POLYARTERETAL died.
Mortality risk
Mortality risk for people of age
years, who have M13_POLYARTERETAL.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.176% | 0.466% |
| 5 | 1.242% | 2.493% |
| 10 | 3.117% | 6.549% |
| 15 | 6.191% | 12.498% |
| 20 | 10.063% | 20.251% |
Relationships between endpoints
↥Index endpoint: M13_POLYARTERETAL – Polyarteritis nodosa and related conditions
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data